Literature DB >> 16551768

Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.

Iftekhar D Kalsekar1, Suresh S Madhavan, Mayur M Amonkar, Eugene H Makela, Virginia G Scott, Stratford M Douglas, Betsy L Meredith Elswick.   

Abstract

BACKGROUND: Adherence to oral hypoglycemic agents (OHAs) is important for adequate glycemic control and prevention of future complications in patients with type 2 diabetes.
OBJECTIVE: To examine the impact of depression on adherence to OHAs in patients newly diagnosed with type 2 diabetes.
METHODS: Patients newly diagnosed with type 2 diabetes during a 4 year period were identified from a Medicaid claims database. Presence of preexisting depression was determined on the basis of ICD-9-CM codes. Adherence to OHAs was computed using prescription refill data for a 12 month follow-up period from the date of the index OHA prescription. Two separate adherence indices (Medication Possession Ratio-1 [MPR-1], Medication Possession Ratio-2 [MPR-2]) were computed. The impact of depression on adherence was assessed after controlling for confounders such as demographics, comorbidity, provider interaction, complexity of regimen, and diabetes severity.
RESULTS: A total of 1326 newly diagnosed patients with type 2 diabetes were identified (depressed = 471; nondepressed = 855). Results of the study indicated that patients with depression had significantly lower adherence (MPR-1 86%; MPR-2 66%) to OHAs compared with patients without depression (MPR-1 89%; MPR-2 73%). Multivariate results indicated that depression was a significant predictor of adherence, with depressed patients being 3-6% less adherent to OHAs than nondepressed patients, after controlling for confounding factors.
CONCLUSIONS: Depression significantly impacts adherence to OHAs in patients with type 2 diabetes. The study results imply that depression screening and treatment need to be included in the protocol for management of patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551768     DOI: 10.1345/aph.1G606

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  19 in total

1.  The relationship between depressive symptoms and medication nonadherence in type 2 diabetes: the role of social support.

Authors:  Chandra Y Osborn; Leonard E Egede
Journal:  Gen Hosp Psychiatry       Date:  2012-03-07       Impact factor: 3.238

2.  How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.

Authors:  Thomas Wilke; Antje Groth; Sabrina Mueller; Dallas Reese; Roland Linder; Susanne Ahrens; Frank Verheyen
Journal:  Eur J Health Econ       Date:  2012-07-20

3.  Regional variation in medication-taking behaviour of new users of oral anti-hyperglycaemic therapy in Ireland.

Authors:  M P O'Shea; M Teeling; K Bennett
Journal:  Ir J Med Sci       Date:  2014-05-25       Impact factor: 1.568

Review 4.  The rational patient and beyond: implications for treatment adherence in people with psychiatric disabilities.

Authors:  Patrick W Corrigan; Nicolas Rüsch; Dror Ben-Zeev; Tamara Sher
Journal:  Rehabil Psychol       Date:  2014-01-20

5.  Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis.

Authors:  Jerry L Grenard; Brett A Munjas; John L Adams; Marika Suttorp; Margaret Maglione; Elizabeth A McGlynn; Walid F Gellad
Journal:  J Gen Intern Med       Date:  2011-05-01       Impact factor: 5.128

6.  Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders.

Authors:  Marsha A Raebel; Jennifer L Ellis; Nikki M Carroll; Elizabeth A Bayliss; Brandy McGinnis; Emily B Schroeder; Susan Shetterly; Stan Xu; John F Steiner
Journal:  J Gen Intern Med       Date:  2011-08-31       Impact factor: 5.128

7.  Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes.

Authors:  J S Gonzalez; S A Safren; L M Delahanty; E Cagliero; D J Wexler; J B Meigs; R W Grant
Journal:  Diabet Med       Date:  2008-09       Impact factor: 4.359

8.  Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity.

Authors:  Jeffrey S Gonzalez; Steven A Safren; Enrico Cagliero; Deborah J Wexler; Linda Delahanty; Eve Wittenberg; Mark A Blais; James B Meigs; Richard W Grant
Journal:  Diabetes Care       Date:  2007-05-29       Impact factor: 19.112

9.  Changes in diabetes distress related to participation in an internet-based diabetes care management program and glycemic control.

Authors:  Stephanie J Fonda; Graham T McMahon; Helen E Gomes; Sara Hickson; Paul R Conlin
Journal:  J Diabetes Sci Technol       Date:  2009-01

10.  Negative affect differentiation and adherence during treatment for thalassemia.

Authors:  Karin G Coifman; Gail S Ross; Dorothy Kleinert; Patricia Giardina
Journal:  Int J Behav Med       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.